Drug Evaluation Committee CRC/CRA Joint Workshop in Kansai: Consistent Quality Management Linking Medical Institutions and Clinical Trial Sponsors - Interactive Workshop for CRCs and CRAs" to be held in person on February 22, 2025

January 22, 2025

The Clinical Evaluation Committee, in collaboration with Osaka University Hospital, has decided to hold a workshop on ensuring the quality of clinical trials in the Kansai region for those involved in clinical trials at medical institutions, SMOs, and pharmaceutical companies/CROs.

In this workshop, we will introduce the necessity of "consistent quality management as a clinical trial" and encourage participants to discuss and discuss actions that can be taken to achieve this goal. We hope that participants will gain a deeper understanding of quality management through this workshop. For details on how to apply for participation and the workshop, please refer to the following website CRC/CRA Joint Workshop in Kansai: Consistent Quality Management Connecting Medical Institutions and Sponsors - An Interactive Workshop for CRCs and CRAs and below. We look forward to your participation.

The series of activities by the Task Force on Clinical Evaluation related to quality management, including this workshop, will be completed this year. We hope you will take advantage of this opportunity.

How to register: Please register at the following URL (Qooker):
URL: https://form.qooker.jp/Q/auto/ja/2024TF21CRCCRAwspre/kansaipre/
QR code of URL:

QR Code

Application deadline: Friday, February 7, 2025

Date & Time】 【Date & Time】 【Venue

Saturday, February 22, 2025, 13:00 - 17:10
Venue】 【Venue

Osaka University Minoh Campus, 3-5-10 Senbahigashi, Minoh, Osaka, Japan
Osaka University of Foreign Studies Memorial Hall

3 minutes walk from Minoh Senba Hanka-mae Station on Kita-Osaka Kyuko Line (directly connected to Midosuji Line of Osaka Metro)
Participation

Face-to-face
Participation fee】 【Participation fee】 【Applicants】 【Target

Free of charge
【target group】

CRC engaged in quality management and CRA engaged in process-focused monitoring at medical institutions who fall under the following categories

  • CRAs who are experiencing problems or issues in their efforts
  • Those who can read the Clinical Evaluation Subcommittee's report "Promoting Consistent Quality Management as a Clinical Trial: Toward Further Collaboration between Sponsors and Medical Institutions" before participating (if possible).
  • Those who are willing to share their learnings after the workshop with their organization and related organizations.
  • Those who are willing to cooperate with the pre- and post-workshop questionnaires.
  • Those who agree to share their e-mail address with those involved in this project.
  • *
    Not only CRC/CRA but also those who are mainly involved in process management in clinical trials (monitoring leaders/monitoring plan developers, CRC leaders, etc.) are welcome to participate.
Number of participants] [Number of applicants] [Number of participants

Up to 60 people (30 each of CRC and CRA)

Return to Drug Evaluation Committee Symposium Top

Share this page

TOP

Site Search